Clinical Trial Guidance Seeks To Improve Sex-Based Data
This article was originally published in The Gray Sheet
Executive Summary
Top goal of recent draft guidance is to increase the proportion of women participating in device trials. The document also emphasizes the types of analyses FDA will expect from device manufacturers to make the most of sex-specific data.